We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
-5.22%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$2.92B
AUM Growth
-$16.5M
Cap. Flow
+$148M
Cap. Flow %
5.06%
Top 10 Hldgs %
58.49%
Holding
3,484
New
270
Increased
1,486
Reduced
1,042
Closed
205

Sector Composition

Rank Sector Weight
1 Technology 6.43%
2 Financials 3.81%
3 Consumer Discretionary 3.81%
4 Healthcare 3.61%
5 Consumer Staples 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
3051
GeneDx Holdings
WGS
$2.05B
$1K ﹤0.01%
42
+4
+11% +$183
WMG icon
3052
Warner Music
WMG
$14.4B
$1K ﹤0.01%
55
WSFS icon
3053
WSFS Financial
WSFS
$4.1B
$1K ﹤0.01%
27
XOP icon
3054
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.59B
$1K ﹤0.01%
11
XPRO icon
3055
Expro Ltd
XPRO
$1.71B
$1K ﹤0.01%
+104
New +$1.26K
ZETA icon
3056
Zeta Global
ZETA
$5.33B
$1K ﹤0.01%
91
FFAI
3057
Faraday Future Intelligent Electric
FFAI
$13.7M
0
LGF.B
3058
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1K ﹤0.01%
136
ACCD
3059
DELISTED
Accolade Inc
ACCD
$1K ﹤0.01%
80
SYRS
3060
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
+87
New +$707
CDMO
3061
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1K ﹤0.01%
39
RCM
3062
DELISTED
R1 RCM Inc. Common Stock
RCM
$1K ﹤0.01%
41
+21
+105% +$479
CBH
3063
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$1K ﹤0.01%
122
+2
+2% +$18
VBIV
3064
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1K ﹤0.01%
33
TWOU
3065
DELISTED
2U Inc
TWOU
$1K ﹤0.01%
6
-15
-71% -$3.9K
CATC
3066
DELISTED
CAMBRIDGE BANCORP
CATC
$1K ﹤0.01%
10
-23
-70% -$1.89K
NWLI
3067
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1K ﹤0.01%
+3
New +$584
FUSN
3068
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
300
KAMN
3069
DELISTED
Kaman Corp
KAMN
$1K ﹤0.01%
26
-130
-83% -$4.06K
GMDA
3070
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1K ﹤0.01%
500
CPE
3071
DELISTED
Callon Petroleum Company
CPE
$1K ﹤0.01%
+23
New +$918
TRHC
3072
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
186
HCCI
3073
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$1K ﹤0.01%
30
-4
-12% -$125
RAD
3074
DELISTED
Rite Aid Corporation
RAD
$1K ﹤0.01%
106
NUVA
3075
DELISTED
NuVasive, Inc.
NUVA
$1K ﹤0.01%
23
-54
-70% -$2.62K

Similar funds

SignatureFD's Q3 2022 Portfolio in Review

As of Q3 2022, SignatureFD held 3,484 positions worth $2.92B, down 0.56% from $2.94B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

SignatureFD deployed $148M of net new capital in Q3 2022, opening 270 new positions and adding to 1,486 existing holdings. Its largest new stake was Haleon: 85,323 shares worth $520K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $174M trimmed.

  • SignatureFD's largest Q3 2022 buy was Haleon: 85,323 shares worth $520K.
  • SignatureFD added most to Vanguard FTSE Emerging Markets ETF in Q3 2022, an estimated $196M increase.
  • SignatureFD's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $174M.
  • SignatureFD fully exited Global X NASDAQ-100 Covered Call ETF in Q3 2022, selling an estimated $429K.
  • SignatureFD's ten largest holdings make up 58% of its $2.92B portfolio in Q3 2022.
  • SignatureFD opened 270 new positions and closed 205 in Q3 2022.
  • SignatureFD's portfolio value fell 0.56% quarter-over-quarter to $2.92B.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.